Integrated Perspectives on Vascular Liver Disorders | AASLD

Integrated Perspectives on Vascular Liver Disorders

Nov 10 2025
Convention Center: Room 146A, Level 1
2:00 PM - 3:30 PM

World Class Speakers

Justin Boike, MD, MPH
Abstract Presenter

Justin Boike, MD, MPH

Northwestern Memorial Hospital/Northwestern University
Elizabeth C Verna, MD, MS, FAASLD
Abstract Presenter

Elizabeth C Verna, MD, MS, FAASLD

Columbia University Medical Center
Riccardo Superina, MD
Abstract Presenter

Riccardo Superina, MD

Ann and Robert H. Lurie Children's Hospital of Chicago
Elizabeth C Verna, MD, MS, FAASLD
Moderator

Elizabeth C Verna, MD, MS, FAASLD

Columbia University Medical Center
Riccardo Superina, MD
Moderator

Riccardo Superina, MD

Ann and Robert H. Lurie Children's Hospital of Chicago

Description

This session encompasses basic, translational, and clinical studies in vascular liver disease and portal hypertension, ranging from congestive hepatopathy and cirrhosis in Fontan-associated liver disease to intrahepatic moecular pathways of fibrosis in chronic liver disease. Key areas also include examination of porto-sinusoidal vascular liver disease and TIPS for acute and chronic portal vein thrombosis. 

Journey Maps

Presentations

2:00 PM - 2:15 PM
Aug 28 2026
Convention Center - Room 146A, Level 1

Metabolic Reprogramming of Glutamine–Glutamate Axis in Fontan-Associated Liver Disease (FALD) 

Justin Boike, MD, MPH , Abstract Presenter
Cirrhosis and Portal Hypertension
2:15 PM - 2:30 PM
Aug 28 2026
Convention Center - Room 146A, Level 1

YAP contributes to liver fibrosis through mediating capillarization of liver sinusoidal endothelial cells via GATA6/eNOS signaling

Elizabeth C Verna, MD, MS, FAASLD , Abstract Presenter
Cirrhosis and Portal Hypertension
2:30 PM - 2:45 PM
Aug 28 2026
Convention Center - Room 146A, Level 1

Association between Liver Related Factors and Post- Cardiac Surgery Mortality

Riccardo Superina, MD , Abstract Presenter
Cirrhosis and Portal Hypertension
2:45 PM - 3:00 PM
Aug 28 2026
Convention Center - Room 146A, Level 1

Role for Endokyne-1 in LSEC–HSC communication and its association with advanced chronic liver disease

Justin Boike, MD, MPH , Abstract Presenter
Cirrhosis and Portal Hypertension
3:00 PM - 3:15 PM
Aug 28 2026
Convention Center - Room 146A, Level 1

Outcomes and Patency of TIPS for Portal Vein Thrombosis from the ALTA Study Group

Justin Boike, MD, MPH , Abstract Presenter
Cirrhosis and Portal Hypertension
3:15 PM - 3:30 PM
Aug 28 2026
Convention Center - Room 146A, Level 1

Clinical Characteristics and Influential Factors of Porto-Sinusoidal Vascular Disease with Portal Hypertension

Riccardo Superina, MD , Abstract Presenter
Cirrhosis and Portal Hypertension

Objectives

  • Describe molecular mechanisms of fibrosis in vascular and chronic liver disease.
  • Discuss mechanisms of hepatopathy in Fontan-associated liver disease as well as clinical implications after cardiac surgery.
  • Evaluate the interactions of vascular liver disorders and portal hypertension, including the role of TIPS.